254 related articles for article (PubMed ID: 32808889)
41. Gd accumulation in tissues of healthy mice upon repeated administrations of Gadodiamide and Gadoteridol.
Di Gregorio E; Iani R; Ferrauto G; Nuzzi R; Aime S; Gianolio E
J Trace Elem Med Biol; 2018 Jul; 48():239-245. PubMed ID: 29773187
[TBL] [Abstract][Full Text] [Related]
42. Nonhomogeneous Gadolinium Retention in the Cerebral Cortex after Intravenous Administration of Gadolinium-based Contrast Agent in Rats and Humans.
Minaeva O; Hua N; Franz ES; Lupoli N; Mian AZ; Farris CW; Hildebrandt AM; Kiernan PT; Evers LE; Griffin AD; Liu X; Chancellor SE; Babcock KJ; Moncaster JA; Jara H; Alvarez VE; Huber BR; Guermazi A; Latour LL; McKee AC; Soto JA; Anderson SW; Goldstein LE
Radiology; 2020 Feb; 294(2):377-385. PubMed ID: 31769744
[TBL] [Abstract][Full Text] [Related]
43. Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.
Kartamihardja AA; Nakajima T; Kameo S; Koyama H; Tsushima Y
Br J Radiol; 2016 Oct; 89(1066):20160509. PubMed ID: 27459250
[TBL] [Abstract][Full Text] [Related]
44. Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents.
Ringler MD; Rhodes NG; Ayers-Ringler JR; Jakaitis DR; McDonald RJ; Kallmes DF; McDonald JS
Skeletal Radiol; 2021 Jul; 50(7):1419-1425. PubMed ID: 33404669
[TBL] [Abstract][Full Text] [Related]
45. Gadolinium retention in a rat model of subtotal renal failure: are there differences among macrocyclic GBCAs?
Bonafè R; Coppo A; Queliti R; Bussi S; Maisano F; Kirchin MA; Tedoldi F
Eur Radiol Exp; 2023 Mar; 7(1):7. PubMed ID: 36855001
[TBL] [Abstract][Full Text] [Related]
46. Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities.
Hannoun S; Issa R; El Ayoubi NK; Haddad R; Baalbaki M; Yamout BI; Khoury SJ; Hourani R
Acad Radiol; 2019 Oct; 26(10):e284-e291. PubMed ID: 30527456
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI.
Bennani-Baiti B; Krug B; Giese D; Hellmich M; Bartsch S; Helbich TH; Baltzer PAT
Radiology; 2019 Dec; 293(3):523-530. PubMed ID: 31638488
[TBL] [Abstract][Full Text] [Related]
48. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
Tweedle MF; Wedeking P; Kumar K
Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
[TBL] [Abstract][Full Text] [Related]
49. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
[TBL] [Abstract][Full Text] [Related]
50. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates.
McDonald RJ; McDonald JS; Dai D; Schroeder D; Jentoft ME; Murray DL; Kadirvel R; Eckel LJ; Kallmes DF
Radiology; 2017 Nov; 285(2):536-545. PubMed ID: 28640692
[TBL] [Abstract][Full Text] [Related]
51. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
Kasper E; Schemuth HP; Horry S; Kinner S
Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
[TBL] [Abstract][Full Text] [Related]
52. Ischemic Stroke Increased Gadolinium Deposition in the Brain and Aggravated Astrocyte Injury After Gadolinium-Based Contrast Agent Administration: Linear Versus Macrocyclic Agents.
Huang XX; Jiang RH; Xu XQ; Zu QQ; Wu FY; Liu S; Shi HB
J Magn Reson Imaging; 2021 Apr; 53(4):1282-1292. PubMed ID: 33555617
[TBL] [Abstract][Full Text] [Related]
53. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
Splendiani A; Perri M; Marsecano C; Vellucci V; Michelini G; Barile A; Di Cesare E
Radiol Med; 2018 Feb; 123(2):125-134. PubMed ID: 28952018
[TBL] [Abstract][Full Text] [Related]
54. Gadolinium-based Contrast Agent Biodistribution and Speciation in Rats.
Le Fur M; Moon BF; Zhou IY; Zygmont S; Boice A; Rotile NJ; Ay I; Pantazopoulos P; Feldman AS; Rosales IA; How IDAL; Izquierdo-Garcia D; Hariri LP; Astashkin AV; Jackson BP; Caravan P
Radiology; 2023 Oct; 309(1):e230984. PubMed ID: 37874235
[TBL] [Abstract][Full Text] [Related]
55. The Effect of Gadolinium-Based Contrast Agents on Longitudinal Changes of Magnetic Resonance Imaging Signal Intensities and Relaxation Times in the Aging Rat Brain.
Green C; Jost G; Frenzel T; Boyken J; Schwenke C; Pietsch H
Invest Radiol; 2022 Jul; 57(7):453-462. PubMed ID: 35125411
[TBL] [Abstract][Full Text] [Related]
56. Gadolinium Retention in the Rat Brain: Assessment of the Amounts of Insoluble Gadolinium-containing Species and Intact Gadolinium Complexes after Repeated Administration of Gadolinium-based Contrast Agents.
Gianolio E; Bardini P; Arena F; Stefania R; Di Gregorio E; Iani R; Aime S
Radiology; 2017 Dec; 285(3):839-849. PubMed ID: 28873047
[TBL] [Abstract][Full Text] [Related]
57. Gadolinium retention in the ischemic cerebrum: Implications for pain, neuron loss, and neurological deficits.
Huang XX; Jiang RH; Xu XQ; Wang W; Sun YQ; Li L; Shi HB; Liu S
Magn Reson Med; 2023 Jan; 89(1):384-395. PubMed ID: 36111354
[TBL] [Abstract][Full Text] [Related]
58. Gadolinium Tissue Distribution in a Large-Animal Model after a Single Dose of Gadolinium-based Contrast Agents.
Richter H; Bücker P; Martin LF; Dunker C; Fingerhut S; Xia A; Karol A; Sperling M; Karst U; Radbruch A; Jeibmann A
Radiology; 2021 Dec; 301(3):637-642. PubMed ID: 34546128
[TBL] [Abstract][Full Text] [Related]
59. Commentary on T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
Runge VM
Invest Radiol; 2015 Aug; 50(8):481-2. PubMed ID: 26107652
[No Abstract] [Full Text] [Related]
60. Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain.
Anderhalten L; Silva RV; Morr A; Wang S; Smorodchenko A; Saatz J; Traub H; Mueller S; Boehm-Sturm P; Rodriguez-Sillke Y; Kunkel D; Hahndorf J; Paul F; Taupitz M; Sack I; Infante-Duarte C
Invest Radiol; 2022 Oct; 57(10):677-688. PubMed ID: 35467573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
